IN2013MN00733A - - Google Patents

Download PDF

Info

Publication number
IN2013MN00733A
IN2013MN00733A IN733MUN2013A IN2013MN00733A IN 2013MN00733 A IN2013MN00733 A IN 2013MN00733A IN 733MUN2013 A IN733MUN2013 A IN 733MUN2013A IN 2013MN00733 A IN2013MN00733 A IN 2013MN00733A
Authority
IN
India
Prior art keywords
disclosed
lubiprostone
intermediates
purifying
preparing
Prior art date
Application number
Other languages
English (en)
Inventor
Julian P Henschke
Yuanlian Liu
Lizhen Xia
Yung Fa Chen
Original Assignee
Scinopharm Kunshan Biochemical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Kunshan Biochemical Technology Co Ltd filed Critical Scinopharm Kunshan Biochemical Technology Co Ltd
Publication of IN2013MN00733A publication Critical patent/IN2013MN00733A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/42—Halogenated unsaturated alcohols acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C07C59/215—Saturated compounds having only one carboxyl group and containing keto groups containing singly bound oxygen containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P31/00—Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN733MUN2013 2010-10-15 2010-10-15 IN2013MN00733A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2010/001614 WO2012048447A1 (fr) 2010-10-15 2010-10-15 Procédés de préparation de lubiprostone

Publications (1)

Publication Number Publication Date
IN2013MN00733A true IN2013MN00733A (fr) 2015-06-12

Family

ID=45937817

Family Applications (1)

Application Number Title Priority Date Filing Date
IN733MUN2013 IN2013MN00733A (fr) 2010-10-15 2010-10-15

Country Status (14)

Country Link
US (2) US8846958B2 (fr)
EP (1) EP2627647B1 (fr)
JP (1) JP5755750B2 (fr)
KR (1) KR101787159B1 (fr)
CN (1) CN103180306B (fr)
AU (1) AU2010362494B2 (fr)
BR (1) BR112013009163A2 (fr)
CA (1) CA2813839C (fr)
ES (1) ES2616023T3 (fr)
IL (1) IL225754A (fr)
IN (1) IN2013MN00733A (fr)
NZ (1) NZ608823A (fr)
TW (1) TWI434837B (fr)
WO (1) WO2012048447A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6079128B2 (ja) * 2012-10-23 2017-02-15 Jsr株式会社 フォトレジスト組成物及びレジストパターン形成方法
KR102311896B1 (ko) 2013-09-30 2021-10-14 패턴 에이피아이 서비시즈 인코포레이티드 복분해를 사용하는 프로스타글란딘 및 프로스타글란딘 중간체의 합성 경로
CN105254657B (zh) * 2014-07-10 2018-06-15 台湾神隆股份有限公司 金属催化不对称1,4-共轭加成反应产生前列腺素和前列腺素类似物
CN104710398A (zh) * 2015-02-17 2015-06-17 齐鲁制药有限公司 鲁比前列酮的新晶型及其制备方法
KR102636648B1 (ko) * 2016-09-13 2024-02-15 삼성전자주식회사 플렉서블 디스플레이 전자 장치
US10457623B1 (en) * 2018-07-13 2019-10-29 Chirogate International Inc. Process for the preparation of Lubiprostone and intermediates thereof
US10253011B1 (en) * 2018-07-13 2019-04-09 Chirogate International Inc. Lubiprostone crystals and methods for preparing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7215294A (en) * 1993-06-29 1995-01-24 Brigham And Women's Hospital Modulation of inflammation related to columnar epithelia
JP4690814B2 (ja) * 2004-08-02 2011-06-01 株式会社アールテック・ウエノ プロスタグランジン誘導体の製造法
TWI384988B (zh) * 2005-01-27 2013-02-11 Sucampo Ag 處理中樞神經系統失常用之組成物
EP2329825B1 (fr) * 2005-03-04 2015-10-07 Sucampo AG Procédé et composition destines au traitement des maladies vasculaires périphériques
JP4648340B2 (ja) * 2006-02-07 2011-03-09 株式会社アールテック・ウエノ １５−ケトプロスタグランジンｅ誘導体の製造法
AR071312A1 (es) 2008-04-09 2010-06-09 Scinopharm Taiwan Ltd Proceso para la preparacion de analogos de prostaglandina y sus intermediarios
US8513441B2 (en) * 2008-08-29 2013-08-20 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
JP5231266B2 (ja) 2009-01-19 2013-07-10 Ｎｔｎ株式会社 等速自在継手の外方部材
US9382272B2 (en) * 2009-01-22 2016-07-05 Apotex Pharmachem Inc. Methods of making lubiprostone and intermediates thereof
CA2784933A1 (fr) * 2009-12-18 2011-06-23 Apotex Pharmachem Inc. Procedes de purification du lubiprostone

Also Published As

Publication number Publication date
NZ608823A (en) 2014-11-28
BR112013009163A2 (pt) 2016-07-26
WO2012048447A1 (fr) 2012-04-19
JP5755750B2 (ja) 2015-07-29
TW201300370A (zh) 2013-01-01
CN103180306A (zh) 2013-06-26
US9012662B2 (en) 2015-04-21
US8846958B2 (en) 2014-09-30
IL225754A0 (en) 2013-06-27
TWI434837B (zh) 2014-04-21
IL225754A (en) 2017-04-30
EP2627647A1 (fr) 2013-08-21
CA2813839C (fr) 2017-03-21
CA2813839A1 (fr) 2012-04-19
CN103180306B (zh) 2015-05-20
AU2010362494A1 (en) 2013-04-18
ES2616023T3 (es) 2017-06-09
JP2014501698A (ja) 2014-01-23
AU2010362494B2 (en) 2015-01-15
KR101787159B1 (ko) 2017-10-18
EP2627647B1 (fr) 2016-12-14
US20150005528A1 (en) 2015-01-01
KR20140027905A (ko) 2014-03-07
EP2627647A4 (fr) 2015-07-29
US20130225842A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
MY179933A (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereof
MX353579B (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
PT2534136T (pt) Métodos para sintetizar agentes de imagiologia, e seus intermediários
TN2012000414A1 (en) Forms of rifaximin and uses thereof
EP2762488A4 (fr) Peptide pour la synthèse de la silice, et son utilisation
EP2550269A4 (fr) Procédé et intermédiaires pour la préparation du lapatinib
IL220523A0 (en) New process for the preparation of dronedarone
EP2651071A4 (fr) Système de microphone sans fil
HUP1000330A2 (en) Process for the preparation of dronedarone and the novel intermediates
IL216935A0 (en) Process for the preparation of nacre mechano-structured by mechanosynthesis, mechano-structured nacre thus obtained and uses thereof
MX2013002784A (es) Heteroarilos fusionados y sus usos.
HK1176526A1 (en) All-purpose wig, method for fitting wig, and customized wig
IN2013MN00733A (fr)
IL222649A0 (en) Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof
EP2630143A4 (fr) Procédés de préparation de rivaroxaban et ses intermédiaires
EP2606116A4 (fr) Système de bioréacteur
HK1179626A1 (en) Process for the preparation of nebivolol
IN2012DN03404A (fr)
IL226153A (en) Process for making nebibolol
EP2606115A4 (fr) Système de bioréacteurs
WO2013072933A3 (fr) Procédé de préparation de 2-acétamido-n-benzyl-3-méthoxypropionamide
MX2012010317A (es) ß-HIDROXIALQUILAMIDAS, METODO PARA SU PRODUCCION Y SU USO.
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
MX2012012489A (es) Preparacion de polipeptidos y sales de los mismos.
WO2010059916A3 (fr) Préparation de docétaxel